Last reviewed · How we verify
NCT04841460
Impact of Beef's Unique Food Matrix on Human Health
NA trial testing Low-fat ground beef in Cholesterol, LDL in 25 participants. Completed in 30 September 2019.
19 July 2019
Quick facts
| Lead sponsor | Texas A&M University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 25 |
| Start date | 18 February 2019 |
| Primary completion | 19 July 2019 |
| Estimated completion | 30 September 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Low-fat ground beef
- High-fat ground beef
Conditions studied
- Cholesterol, LDL — all drugs for Cholesterol, LDL →
- Cholesterol, HDL — all drugs for Cholesterol, HDL →
- Research Subjects — all drugs for Research Subjects →
Sponsor
Texas A&M University
Who can join
Eligibility, male only, with Cholesterol, LDL or Cholesterol, HDL. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary goal of the proposed research is to document changes in plasma lipoprotein fractions, including high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particle sizes and functionality, following the ground beef interventions. This specifically addresses the hypothesis that increasing the amount of fat in ground beef reduces risk factors for cardiovascular disease. Also, the investigators will measure changes in glucose, insulin, and triacylglycerols (TAG) following low-fat and high-fat ground beef interventions. An important aspect of this research is that the investigators will confirm that consumption of high-fat ground beef will reduce carbohydrate intake and increase insulin sensitivity in men. Furthermore, the investigators will be able to establish which protein sources are voluntarily replaced by the low- and high-fat ground beefs.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Consuming High-Fat and Low-Fat Ground Beef Depresses High-Density and Low-Density Lipoprotein Cholesterol Concentrations, and Reduces Small, Dense Low-Density Lipoprotein Particle Abundance.
Lytle JR, Price T, Crouse SF, Smith DR, et al · · 2023 · cited 4× · PMID 36678207 · DOI 10.3390/nu15020337 -
Assessment of Vascular Function in Response to High-Fat and Low-Fat Ground Beef Consumption in Men.
Lytle JR, Stanelle ST, Martin SE, Smith SB, et al · · 2023 · cited 2× · PMID 36986140 · DOI 10.3390/nu15061410 -
High unprocessed beef intake (>100 g/d) linked to elevated triglyceride levels: evidence from cross-sectional and Mendelian randomization in Chinese and American adult populations.
Yi Z, Ding S, Liu X, Liu S, et al · · 2026 · PMID 42221767 · DOI 10.3389/fnut.2026.1790394
Verify or expand the search:
- PubMed search for NCT04841460
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Texas A&M University trials
Trials by the same sponsor.
- NCT07079995 — Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial · NA · recruiting
- NCT06950775 — The Neighborhood & Health Study · recruiting
- NCT06890689 — Effectiveness of Scaling and Root Planing in Deeper Pockets · active not recruiting
- NCT06797089 — Does myTAP Oral Appliance Therapy Including a Mouth Shield Lessen Periodontitis in Mouth-Breathers Who Snore? · NA · completed
- NCT05959434 — Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04841460 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Texas A&M University
- Last refreshed: 12 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04841460.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing